Recommendations for patient involvement in health technology assessment in Central and Eastern European countries
Анотація
Introduction: Meaningful patient involvement in health technology assessment (HTA) is essential in ensuring that the interests of the affected patient population, their families, and the general public are accurately reflected in coverage and reimbursement decisions. Central and Eastern European (CEE) countries are generally at less advanced stages of implementing HTA, which is particularly true for patient involvement activities. As part of the Horizon2020 HTx project, this research aimed to form recommendations for critical barriers to patient involvement in HTA in CEE countries. Methods: Built on previous research findings on potential barriers, a prioritisation survey was conducted online with CEE stakeholders. Recommendations for prioritised barriers were formed through a face-to-face workshop by CEE stakeholders and HTx experts. Results: A total of 105 stakeholders from 13 CEE countries completed the prioritisation survey and identified 12 of the 22 potential barriers as highly important. The workshop had 36 participants representing 9 CEE countries, and 5 Western European countries coming together to discuss solutions in order to form recommendations based on best practices, real-life experience, and transferability aspects. Stakeholder groups involved in both phases included HTA organisation representatives, payers, patients, caregivers, patient organisation representatives, patient experts, health care providers, academic and non-academic researchers, health care consultants and health technology manufacturers/providers. As a result, 12 recommendations were formed specified to the CEE region's context, but potentially useful for a broader geographic audience. Conclusion: In this paper, we present 12 recommendations for meaningful, systematic, and sustainable patient involvement in HTA in CEE countries. Our hope is that engaging more than a hundred CEE stakeholders in the study helped to spread awareness of the importance and potential of patient involvement and that the resulting recommendations provide tangible steps for the way forward. Future studies shall focus on country-specific case studies of the implemented recommendations.
Класифікація
Ідентифікатори
Рецензії (0)
Написати рецензіюРецензій ще немає. Будьте першим!
Схожі роботи
Drug Regulatory Systems Must Foster Innovation
Схоже за: Biomedical Ethics and Regulation · Health Systems, Economic Evaluations, Quality of Life
The European Cancer Patient’s Bill of Rights, update and implementation 2016
Схоже за: Health Systems, Economic Evaluations, Quality of Life
Double-Crossed: Why Crossover in Clinical Trials May Be Distorting Medical Science
Схоже за: Health Systems, Economic Evaluations, Quality of Life
Modern approaches to typologization and modeling in the health technology assessment
Схоже за: Health Systems, Economic Evaluations, Quality of Life
EXPERT EVALUATION OF THE CLINICAL TRIAL MANAGEMENT MODEL WITH AN OPTIMIZED REGULATORY SYSTEM AT THE LEVEL OF A CONTRACT RESEARCH ORGANIZATION
Схоже за: Health Systems, Economic Evaluations, Quality of Life
Continuing education in geriatrics: An imperative for elderly care
Схоже за: Health Systems, Economic Evaluations, Quality of Life